These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21705677)

  • 1. Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.
    Egom EE; Mohamed TM; Mamas MA; Shi Y; Liu W; Chirico D; Stringer SE; Ke Y; Shaheen M; Wang T; Chacko S; Wang X; Solaro RJ; Fath-Ordoubadi F; Cartwright EJ; Lei M
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1487-95. PubMed ID: 21705677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.
    Egom EE; Ke Y; Musa H; Mohamed TM; Wang T; Cartwright E; Solaro RJ; Lei M
    J Mol Cell Cardiol; 2010 Feb; 48(2):406-14. PubMed ID: 19852968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
    Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.
    Vessey DA; Li L; Imhof I; Honbo N; Karliner JS
    Med Sci Monit Basic Res; 2013 Apr; 19():126-32. PubMed ID: 23567658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
    Liu W; Zi M; Naumann R; Ulm S; Jin J; Taglieri DM; Prehar S; Gui J; Tsui H; Xiao RP; Neyses L; Solaro RJ; Ke Y; Cartwright EJ; Lei M; Wang X
    Circulation; 2011 Dec; 124(24):2702-15. PubMed ID: 22082674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
    Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
    Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion.
    Hofmann U; Hu K; Walter F; Burkard N; Ertl G; Bauersachs J; Ritter O; Frantz S; Bonz A
    Br J Pharmacol; 2010 Jul; 160(5):1243-51. PubMed ID: 20590616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
    Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
    Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
    Qin X; Yue Z; Sun B; Yang W; Xie J; Ni E; Feng Y; Mahmood R; Zhang Y; Yue L
    Br J Pharmacol; 2013 Mar; 168(6):1294-312. PubMed ID: 23145923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes.
    Karliner JS; Honbo N; Summers K; Gray MO; Goetzl EJ
    J Mol Cell Cardiol; 2001 Sep; 33(9):1713-7. PubMed ID: 11549349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1-Phosphate Improves the Biological Features of Mouse Bone Marrow-Derived EPCs Partially through PI3K/AKT/eNOS/NO Pathway.
    Wang X; Zhan E; Lu G; Mu Q; Zhang T; Yang N
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31261859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
    Rana A; Sharma S
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation.
    Fang R; Zhang LL; Zhang LZ; Li W; Li M; Wen K
    Arch Med Res; 2017 Feb; 48(2):147-155. PubMed ID: 28625317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection.
    Zhao X; Ding EY; Yu OM; Xiang SY; Tan-Sah VP; Yung BS; Hedgpeth J; Neubig RR; Lau LF; Brown JH; Miyamoto S
    J Mol Cell Cardiol; 2014 Oct; 75():152-61. PubMed ID: 25106095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes.
    Egom EE; Bae JS; Capel R; Richards M; Ke Y; Pharithi RB; Maher V; Kruzliak P; Lei M
    Mol Cell Biochem; 2016 Aug; 419(1-2):83-92. PubMed ID: 27372350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3.
    Kelly-Laubscher RF; King JC; Hacking D; Somers S; Hastie S; Stewart T; Imamdin A; Maarman G; Pedretti S; Lecour S
    Cardiovasc J Afr; 2014; 25(3):118-23. PubMed ID: 25000441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective role of sphingosine-1-phosphate.
    Knapp M
    J Physiol Pharmacol; 2011 Dec; 62(6):601-7. PubMed ID: 22314562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
    Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
    Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.